What’s the buzz—

message boards

Par Pharmaceutical

PRX

Par Pharmaceutical is a holding company that, mostly through its wholly owned subsidiary, Par Pharmaceutical, Inc., is in the business of developing, manufacturing and distributing generic and branded drugs in the United States. During the year ended December 2006, the Company announced its divestiture of FineTech Laboratories, Ltd. As a result of the divestiture, the business is being reported as a discontinued operation for all periods presented, as applicable. The company distributes approximately 80 products, representing various dosage strengths for 40 separate drugs that are manufactured by the company and 100 additional products, representing various dosage strengths for 41 separate drugs that are manufactured for it by other companies. Par Pharmaceutical holds the Abbreviated New Drug Applications and New Drug Applications for the drugs that it manufactures.

Stock Quotes and Other Information

Nasdaq	NYSE	Msn	Yahoo	Silicon Investor
Excite	Lycos	Market Watch	Clear Station	StockHouse

SourceOne Message Board

Search for Stocks:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Alphabetical Listings by Company Name

S&P 100 S&P 500 S&P 400 Dow Jones Industrials Dow Jones Transportation Dow Jones Utilities Dow Jones Composite Nasdaq 100 Morgan Stanley Hi-Tech 35

Home

Investor Relations

Stock Quotes and Other Information

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z